The use of self-measured blood pressure determinations in assessing dynamics of drug compliance in a study with amlodipine once a day, morning versus evening

Journal of Hypertension

Volumn 11, Issue 12, 1993, Pages 1403-1411

  Mengden, Thomas ^a   Binswanger, Benedikt ^a   Spühler, Thomas ^a   Weisser, Burkhard ^a   Vetter, Wilhelm ^a  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

Ambulatory blood pressure measurement; Antihypertensive efficacy; Blood pressure monitoring; Calcium antagonist; Compliance; Self measurement

Indexed keywords

AMLODIPINE; CALCIUM ANTAGONIST;

ADULT; AGED; AMBULATORY MONITORING; ARTICLE; BLOOD PRESSURE MEASUREMENT; BLOOD PRESSURE MONITORING; BLOOD PRESSURE REGULATION; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DRUG EFFICACY; EDEMA; FATIGUE; FEMALE; FLUSHING; HEADACHE; HEART PALPITATION; HUMAN; HYPERTENSION; MALE; NIGHTMARE; ORAL DRUG ADMINISTRATION; OUTPATIENT; PATIENT COMPLIANCE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SELF EXAMINATION;

ADULT; AGED; AGED, 80 AND OVER; AMLODIPINE; BLOOD PRESSURE; BLOOD PRESSURE DETERMINATION; DRUG ADMINISTRATION SCHEDULE; FEMALE; HEART RATE; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; MONITORING, PHYSIOLOGIC; PATIENT COMPLIANCE; SELF ADMINISTRATION; SELF CARE;

EID: 0027768946     PISSN: 02636352     EISSN: 14735598     Source Type: Journal    
DOI: 10.1097/00004872-199312000-00013     Document Type: Article

References (46)

1. Faulkner JK, McGibney D, Chasseaud LF, Perry JL, Taylor IW: The pharmacokinetics of amlodipine in healthy volunteers after single intravenous and oral doses and after 14 repeated oral doses given once daily. Br J Clin Pharmacol 1986, 22:21–25.
2. Heber ME, Brigden G, Al-Khawaja I, Raftery EB: 24 h blood pressure control with the once daily calcium antagonist, amlodipine. Br J Clin Pharmacol 1989, 27:359–365.
3. Mroczek WJ, Burris JF, Allenby KS: A double-blind evaluation of the effect of amlodipine on ambulatory blood pressure in hypertensive patients. J Cardiovasc Pharmacol 1988,(suppl 7):S79–S84.
4. Webster J, Robb OJ, Jeffers A, Scott AK, Petrie JC, Towler HM: Once daily amlodipine in the treatment of mild to moderate hypertension. Br J Clin Pharmacol 1987, 24:713–719.
5. Kubacha RT, Juhl RP: Attitudes of patients with hypertension or arthritis towards the frequency of medication administration. Am J Hosp Pharm 1985, 42:2499–2501.
6. Blackwell B: Drug therapy: patient compliance. N Engt J Med 1973, 289:249–252.
7. Haynes RB: A critical review of the ‘determinants’ of patient compliance with therapeutic regimen. In Compliance with Therapeutic Regimens. Edited by Sackett DL, Haynes RB. Baltimore: Johns Hopkins University Press; 1976:27–39.
8. Luscher TF, Vetter H, Siegenthaler W, Vetter W: Compliance in hypertension: facts and concepts. J Hypertens 1985,(suppl 1):3–9.
9. Gordis L: Conceptual and methodological problems in measuring patient compliance. In Compliance in Health Care. Edited by Haynes RB, Taylor DW, Sacken DL. Baltimore: Johns Hopkins University Press; 1979:35–60.
10. Meyers A, Dewar HA: Circumstances attending 100 deaths from coronary artery disease with coroners’ necropsies. Br Heart J 1975, 37:1113–1143.
11. Muller JE, Ludmer PL, Wiluch SN, Tofler GH, Aylmer G, Klangos I, et al.: Orcadian variation in the frequency of sudden cardiac death. Circulation 1987, 75:131–138.
12. Agnoli A, Manfredi M, Mossuto L, Picinelli A: Relationship between circadian rhythms and blood pressure and the pathogenesis of ccrebrovascular insufficiency. Rev Neu-rol 1975, 131:597–606.
13. Neutel JM, Schnaper H, Cheung DG, Graettinger WF, Weber MA: Antihypertensivc efficacy of β-blockers administered once dairy: 24-hour measurements. Am Heart J 1990, 120:166–171.
14. White BW: Methods of blood pressure determination to assess antihypeitensive agents: are casual measurements enough? Clin Pharmacol Ther 1989, 45:581–586.
15. Mengden T, Schubert M, Jeck T, Edmonds D, Vetter W: Casual versus ambulatory twenty-four-hour blood pressure measurement in a comparative study with bisoprolol or ni-trendipine. J Hypertens 1990,(suppl 4):S91–S94.
16. Waeber B, Scherrer U, Petrillo A, Bldlvule J, Nussberger J, Waeber G, et al.: Are some hypertensive patients overtreated? A prospective study of ambulatory blood pressure recording. Lancet 1987, ii:732–734.
17. Weisser B, Mengden T, Vetter W: Ambulatory twenty-four-hour blood pressure measurements in pharmcological studies. J Hypertens 1990,(suppl 6):S87–S92.
18. Cottier C, Julius S, Gajendragadkar SV, Shork A: Usefulness of home blood pressure determination in treating borderline hypertension. JAMA 1982, 248:555–558.
19. Gould BA, Hornung RS, Kieso H, Cashman PMM, Raftery ER: An evaluation of self-recorded blood pressure during drug trials. Hypertension 1986, 8:267–271.
20. Mengden T, Battig B, Vetter W: Self-measurement of blood pressure improves the accuracy and reduces the number of subjects in clinical trials. J Hypertens 1991,(suppl 6):S336–S337.
21. Kirkendall WM, Ffjnleib M, Freis ED, Mark AL: Rccom-mendations for human blood pressure determination by sphygmomanomcters. Circulation 1980, 62:1146A–1155A.
22. O’Brien E, Sheridan J, Browne T, Conroy R, O’Malley K: Validation of the Spacelabs 90202 ambulatory blood pressure recorder [abstract]. J Hypertens 1989,(suppl 6):S388–S389.
23. Graettinger WF, Llpson JL, Cheung DJ: Validation of os-cillomctric, auscultatory and r-wave gated auscultatory automated portable blood pressure measurements by intra-arterial line and sphygmomanometer. Am Heart J 1988, 116:1155–1160.
24. Weber MA, Cheung DG, Graettinger WF, Lipson JL: Characterization of antihypeitensive therapy by whole-day blood pressure monitoring. JAMA 1988, 259:3281–3285.
25. Anlauf M, Kribben A, Weber F: Self-assessment of blood pressure: automation and handling problems. Schweiz Rundsch Med Praxis 1992, 81:106–110.
26. Rudd P, Marshall G, Taylor CB, Agras WS: Medication monitor-dispenser for pharmacological and compliance research. Clin Pharmacol Ther 1981, 29:278–282.
27. Kruse W, Weber E: Dynamics of drug regimen compliance —its assessment by microprocessor-based monitoring. Eur J Clin Pharmacol 1990, 38:561–565.
28. Palatini P, Racioppa A, Raule G, Zaninotto M, Penzo M, Pessina AC: Effect of timing of administration on the plasma ACE inhibitory activity and the antihypertensivc effect of quinapril. Clin Pharmacol Ther 1992, 52:378–383.
29. White WB: Predicting hypertensive heart disease via non-invasive methodology: relationship between ambulatory blood pressure and cardiac indices derived by echocardiogra-phy and radionuclide ventriculography. J Hypertens 1990,(suppl 6):S113–S118.
30. Mengden T, Battig B, Schubert M, Jeck T, Weisser B, Buddeberg C, et al.: Comparison of causal, ambulatory and self-measured blood pressure in a study with nitrendipine vs bisoprolol. Eur J Clin Pharmacol 1992, 42:569–575.
31. Brown GE: Daily and monthly rhythm in the blood pressure of a man with hypertension. Ann Intern Med 1930, 3:1177–1189.
32. Ayman D, Goldshine AD: Blood pressure determinations by patients with essential hypertension. Am J Med Sci 1940, 200:465–473.
33. Mengden T, Battig B, Edmonds D, Jeck T, Huss R, Sachinidis A, et al.: Self-measured blood pressures at home and during consulting hours: are there any differences? J Hypertens 1990,(suppl 4):S15–S19.
34. Kleinert HD, Harshfield GA, Laragh JH: What is the value of home blood pressure measurements in patients with mild hypertension? Hypertension 1984, 6:574–578.
35. Conway J, Coats A, Radaelli A: Ambulatory blood pressure in relation to drug treatment and clinical trials. J Hypertens 1990,(suppl 6):S83–S85.
36. Mengden T, Binswanger B, Weisser B, Vetter W: An evaluation of self-measured blood pressure in a study with a calcium channel antagonist versus a beta-blockcr. Am J Hypertens 1992, 5:154–160.
37. Cramer JA, Scheyer RD, Mattson RH: Compliance declines between clinic visits. Arch Intern Med 1990, 150:1509-1510.
38. Feinstein AR: On white-coat effects and the electronic monitoring of compliance. Arch Intern Med 1990, 150:1377-1378.
39. Sheiner LB: The intellectual health of cinical drug evaluation. Clin Pharmacol Ther 1991, 50:4-9.
40. Joyce CRB: Patient cooperation and the sensitivity of clinical trials. J Chronic Dis 1962, 15:1025-1036.
41. Efron B, Feldman D: Compliance as an explanatory variable in clinical trials. J Am Slat Assoc 1991, 86:7-17.
42. Edmonds D, Foerster E, Groth H, Greminger P, Siegenthaler W, Vetter W: Does self-measurement of blood pressure improve patient compliance in hypertension? J Hypertens 1985,(suppl 1):31-34.
43. Kruse W, Eggert-Kruse W, Rampmaier J, Runnebaum B, Weber E: Dosage frequency and drug-compliance behaviour —a comparative study on compliance with a medication to be taken twice or four times daily. EurJ Clin Pharmacol 1991, 41:589-592.
44. de Bruijn B, Cocco G, Tyler HM: Multicenter placebo-controlled comparison of amlodipine and atenolol in mild to moderate hypertension. J Cardiovasc Pharmacol 1988,(suppl 7):S107-S109.
45. Rofman BA: Long-term open evaluation of amlodipine versus hydrochlorothiazide in patients with essential hypertension. J Cardiovasc Pharmacol 1988,(suppl 7):S94-S97.
46. Edmonds D, Knorr M, Greminger P, Walger P, Frieungsdorf J, Vetter H, et al.: ACE inhibitor versus beta-blocker in the treatment of essential hypertension. Nephron 1987,(suppl 1):90-93.